JP2014512382A5 - - Google Patents

Download PDF

Info

Publication number
JP2014512382A5
JP2014512382A5 JP2014506434A JP2014506434A JP2014512382A5 JP 2014512382 A5 JP2014512382 A5 JP 2014512382A5 JP 2014506434 A JP2014506434 A JP 2014506434A JP 2014506434 A JP2014506434 A JP 2014506434A JP 2014512382 A5 JP2014512382 A5 JP 2014512382A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
functional
mnp
composition according
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506434A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014512382A (ja
JP6038122B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/032100 external-priority patent/WO2012145169A2/en
Publication of JP2014512382A publication Critical patent/JP2014512382A/ja
Publication of JP2014512382A5 publication Critical patent/JP2014512382A5/ja
Application granted granted Critical
Publication of JP6038122B2 publication Critical patent/JP6038122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506434A 2011-04-21 2012-04-04 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用 Active JP6038122B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161477958P 2011-04-21 2011-04-21
US61/477,958 2011-04-21
PCT/US2012/032100 WO2012145169A2 (en) 2011-04-21 2012-04-04 Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016212546A Division JP6353007B2 (ja) 2011-04-21 2016-10-31 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用

Publications (3)

Publication Number Publication Date
JP2014512382A JP2014512382A (ja) 2014-05-22
JP2014512382A5 true JP2014512382A5 (https=) 2015-05-21
JP6038122B2 JP6038122B2 (ja) 2016-12-07

Family

ID=47042109

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014506434A Active JP6038122B2 (ja) 2011-04-21 2012-04-04 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用
JP2016212546A Active JP6353007B2 (ja) 2011-04-21 2016-10-31 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用
JP2018109290A Active JP6960883B2 (ja) 2011-04-21 2018-06-07 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016212546A Active JP6353007B2 (ja) 2011-04-21 2016-10-31 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用
JP2018109290A Active JP6960883B2 (ja) 2011-04-21 2018-06-07 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用

Country Status (9)

Country Link
US (3) US9272055B2 (https=)
EP (2) EP3345545B1 (https=)
JP (3) JP6038122B2 (https=)
KR (1) KR20140012732A (https=)
CN (2) CN106729771A (https=)
AU (3) AU2012245861A1 (https=)
CA (2) CA3058702C (https=)
ES (1) ES2667894T3 (https=)
WO (1) WO2012145169A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103157414B (zh) * 2013-03-28 2014-10-01 天津理工大学 一种聚缩水甘油表面接枝的铁磁纳米粒子的制备方法
WO2019028062A1 (en) * 2017-07-31 2019-02-07 Washington University PIRFENIDONE DERIVATIVES FOR MODULATION OF B-LYMPHOCYTE ACTIVITY AND PROTECTION OF ORGANS
JP7450812B2 (ja) 2021-05-18 2024-03-15 三菱電機株式会社 生体情報検出装置および生体情報検出装置の作動方法
DE102023003949A1 (de) 2023-09-30 2025-04-03 Carola Kryschi Eisensulfid-Nanopartikel als Enzym-mimetische Nanokatalysatoren (nanoXcats)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343530A1 (de) 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA2025907A1 (en) 1989-09-21 1991-03-22 Franklin D. Collins Method of transporting compositions across the blood brain barrier
US5411730A (en) 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
JPH11510837A (ja) 1995-07-28 1999-09-21 フォーカル,インコーポレイテッド 薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
US7964598B2 (en) 1995-10-17 2011-06-21 The J. David Gladstone Institutes ApoE4 domain interaction inhibitors and methods of use thereof
CA2340394A1 (en) * 1998-08-20 2000-03-02 Jorge R. Barrio Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles
US6767635B1 (en) 1999-09-14 2004-07-27 Biomedical Apherese Systeme Gmbh Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6534039B2 (en) 2000-07-21 2003-03-18 James F. Hainfeld Extended organic cobalt and nickel magnetic complexes
US7270800B2 (en) * 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6714138B1 (en) 2000-09-29 2004-03-30 Aps Technology, Inc. Method and apparatus for transmitting information to the surface from a drill string down hole in a well
WO2002028441A2 (en) 2000-10-04 2002-04-11 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
US6821504B2 (en) 2001-05-23 2004-11-23 New York University Detection of alzheimer's amyloid by magnetic resonance imaging
GB0117326D0 (en) 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
KR100754596B1 (ko) 2001-09-21 2007-09-05 미쯔비시 웰 파마 가부시키가이샤 3-치환-4-피리미돈 유도체
EP1547996A4 (en) * 2002-08-30 2006-08-02 Bf Res Inst Inc DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES IN WHICH PRION PROTEIN IS ACCUMULATED, AND ANIMAL FEVERING FOR PRION PROTEIN
CN1312479C (zh) * 2003-08-08 2007-04-25 清华大学 一种纳米荧光磁粒及其制备方法
EP1789046A2 (en) * 2004-08-16 2007-05-30 Queen Mary University of London Peripheral benzodiazepine receptor independent superoxide generation
SG194363A1 (en) * 2004-12-17 2013-11-29 Univ Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
ATE507250T1 (de) * 2005-02-10 2011-05-15 Qiagen Gmbh Probenlyse und beschichtung einer reaktionsoberfläche
KR101306641B1 (ko) 2005-03-21 2013-09-12 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 작용화된 자성 나노입자 및 이의 사용방법
TW200736252A (en) 2006-01-27 2007-10-01 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
HRP20120135T1 (hr) * 2006-03-30 2012-03-31 The Trustees Of The University Of Pennsylvania Derivati stirilpiridina i njihova upotreba kod vezanja na i vizualizacije amiloidnih plakova
US7737183B2 (en) * 2006-10-17 2010-06-15 The Regents Of The University Of California β-amyloid and neurofibrillary tangle imaging agents
FR2913886B1 (fr) * 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
CN101544584B (zh) * 2008-03-26 2013-09-25 中国医学科学院放射医学研究所 阿尔茨海默病显像剂前体物的制备方法
US8445021B2 (en) * 2008-04-04 2013-05-21 The Regents Of The University Of California Functionalized magnetic nanoparticles and methods of use thereof
CA2731738A1 (en) 2008-07-24 2010-01-28 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying ad pathology
RS55674B1 (sr) * 2008-12-31 2017-06-30 Avid Radiopharmaceuticals Inc Sinteza 18f-radio obeleženih stirilpiridina od tozilat prekursora i njihovih stabilnih farmaceutskih kompozicija

Similar Documents

Publication Publication Date Title
Veronesi et al. Imaging of intranasal drug delivery to the brain
Kulkarni et al. Quinoline‐n‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease
Yan et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier
Zhang et al. Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging
US20170232120A1 (en) Dendrimer compositions and use in treatment of neurological and cns disorders
Steeland et al. TNFR1 inhibition with a Nanobody protects against EAE development in mice
JP2014512382A5 (https=)
Russell et al. The potential impact of nanomedicine on COVID-19-induced thrombosis
Liao et al. Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice
Kniess et al. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection
US20240398979A1 (en) Compositions and Methods for Treating Dopamine Disorders
Chen et al. A novel human detoxification system based on nanoscale bioengineering and magnetic separation techniques
JP6960883B2 (ja) 機能性磁性ナノ粒子、ならびにアミロイド沈着物および神経原繊維濃縮体の画像処理における使用
AU2019257499A1 (en) Method for preventing and/or treating chronic traumatic encephalopathy-II
Chen et al. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide
Risinger et al. Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study
Zhao et al. Combined treatment of sodium ferulate, n‐butylidenephthalide, and ADSC s rehabilitates neurovascular unit in rats after photothrombotic stroke
KR102460465B1 (ko) 알츠하이머병(ad)의 치료 및 예방
JP2020512338A5 (https=)
KR102506460B1 (ko) 알츠하이머병(ad)의 치료 및 예방
WO2020238800A1 (zh) 用于肿瘤的靶向放射性药物及其在影像指导下的靶向放射治疗与免疫治疗的联合疗法
JP2024529341A (ja) 粒子が付着している細胞に関連する組成物および方法
US20170196998A1 (en) Nanoparticle contrast agent for early diagnosis of alzheimer's disease by magnetic resonance imaging (mri)
JP2006525289A (ja) ペプチド誘導体を用いたinvivo画像化方法
JP2017518275A (ja) アルツハイマー病(ad)の処置および予防